Vardenafil for the treatment of erectile dysfunction in men with diabetes / 中华男科学杂志
National Journal of Andrology
;
(12): 794-797, 2004.
Artigo
em Chinês
| WPRIM
| ID: wpr-267811
ABSTRACT
The prevalence of erectile dysfunction (ED) is higher in diabete patients than in non-diabete men. Moreover, the treatment of ED is more challenging in men with diabetes. Vardenafil, a novel and highly selective phosphodiesterase 5 inhibitor, is the first line therapy for the broad ED population. Recent large-scale clinical trials indicated that vardenafil improved erectile function in ED men with diabetes regardless of the baseline ED severity and plasma HbA1c levels, and it was generally well tolerated.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Inibidores de Fosfodiesterase
/
Piperazinas
/
Sulfonas
/
Triazinas
/
Inquéritos e Questionários
/
Resultado do Tratamento
/
Usos Terapêuticos
/
Complicações do Diabetes
/
Tratamento Farmacológico
/
Dicloridrato de Vardenafila
Limite:
Humanos
/
Masculino
Idioma:
Chinês
Revista:
National Journal of Andrology
Ano de publicação:
2004
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS